Dietary intervention of flaxseed: Effect on serum levels of IGF-1, IGF-BP3, and C-peptide

Nutrition and Cancer

Volumn 63, Issue 3, 2011, Pages 376-380

  Sturgeon, Susan R ^a   Volpe, Stella L ^b   Puleo, Elaine ^a   Bertone Johnson, Elizabeth R ^a   Heersink, Joanna ^a   Sabelawski, Sara ^a   Wähälä, Kristina ^c   Bigelow, Carol ^a   Kurzer, Mindy S ^d  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CANCER RISK; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; LINSEED; MAJOR CLINICAL STUDY; NUTRITIONAL HEALTH; POSTMENOPAUSE;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY MASS INDEX; C-PEPTIDE; DIET; FEMALE; FLAX; FOLLOW-UP STUDIES; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTERVENTION STUDIES; MIDDLE AGED; POSTMENOPAUSE; QUESTIONNAIRES; RISK FACTORS;

EID: 79957568532     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.535964     Document Type: Article

References (27)

1. Pollak M: Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8, 915-928, 2008.
2. Pisani P: Hyper-insulinaemia and cancer,meta-analyses of epidemiological studies. Arch Physiol Biochem 114, 63-70, 2008.
3. Yu H and Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92, 1472-1489, 2000.
4. Mazur W: Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab 12, 729-742, 1998.
5. Romeo JT (Ed.): Recent Advances in Phyochemistry. Phytochemicals in Human Health Protection, Nutrition, and Plant Defense. Kluwer Academic/Plenun Publishers, New York, 1999.
6. Pollak MN, Huynh HT, and Lefebvre SP: Tamoxifen reduces serum insulin-like growth factor I (IGF-I). Breast Cancer Res Treat 22, 91-100, 1992.
7. Rickard SE, Yuan YV, and Thompson LU: Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside. Cancer Lett 161, 47-55, 2000.
8. Prasad K, Mantha SV, Muir AD, and Westcott ND: Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol Cell Biochem 206, 141-149, 2000.
9. Prasad K: Secoisolariciresinol diglucoside from flaxseed delays the development of type 2 diabetes in Zucker rat. J Lab Clin Med 138, 32-39, 2001.
10. Prasad K: Suppression of phospoenolpyruvate carboxykinase gene expression by secoisolariciresinol diglucoside (SDG), a new antidiabetic agent. Int J Angiol 11, 107-109, 2002.
11. Sturgeon SR, Heersink JL, Volpe SL, Bertone-Johnson ER, Puleo E, et al.: Effect of dietary flaxseed on serum levels of estrogens and androgens in postmenopausal women. Nutr Cancer 60, 612-618, 2008.
12. Hebert JR, Ockene IS, Hurley TG, Luippold R, Well AD, et al.: Development and testing of a seven-day dietary recall: Dietary Assessment Working Group of the Worcester Area Trial for Counseling in Hyperlipidemia (WATCH). J Clin Epidemiol 50, 925-937, 1997.
13. Xu X, Duncan AM, Merz BE, and Kurzer MS: Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 7, 1101-1108, 1998. (Pubitemid 29001666)
14. Willett WC (Ed.): Nutritional Epidemiology. Oxford University Press, New York, 1998.
15. Sturgeon SR, Volpe SL, Puleo E, Bertone-Johnson ER, Heersink J, et al.: Effects of flaxseed consumption on urinary levels of estrogen metabolites in postmenopausal women. Nutr Cancer 62, 175-180, 2010.
16. Lucas EA, Wild RD, Hammond LJ, Khalil DA, Juma S, et al.: Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87, 1527-1532, 2002. (Pubitemid 34615233)
17. Woodside JV, Campbell MJ, Denholm EE, Newton L, Honour JW, et al.: Short-term phytoestrogen supplementation alters insulin-like growth factor profile but not lipid or antioxidant status. J Nutr Biochem 17, 211-215, 2006. (Pubitemid 43247416)
18. Cunnane SC, Hamadeh MJ, Liede AC, Thompson LU, Wolever TM, et al.: Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 61, 62-68, 1995.
19. Cunnane SC, Ganguli S, Menard C, Liede AC, Hamadeh MJ, et al.: High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr 69, 443-453, 1993. (Pubitemid 23105482)
20. Stuglin C and Prasad K: Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humans. J Cardiovasc Pharmacol Ther 10, 23-27, 2005.
21. Dodin S, Cunnane SC, Masse B, Lemay A, Jacques H, et al.: Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition 24, 23-30, 2008 (Pubitemid 350225655)
22. Lemay A, Dodin S, Kadri N, Jacques H, and Forest JC: Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 100, 495-504, 2002. (Pubitemid 35246136)
23. Barre DE, Mizier-Barre KA, Griscti O, and Hafez K: High dose flaxseed oil supplementation may affect fasting blood serum glucose management in human type 2 diabetics. J Oleo Sci 57, 269-273, 2008.
24. Pan A, Sun J, Chen Y, Ye X, Li H, et al.: Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One 2, e1148, 2007.
25. Zhang W, Wang X, Liu Y, Tian H, Flickinger B, et al.: Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 99, 1301-1309, 2008.
26. Schwab US, Callaway JC, Erkkila AT, Gynther J, Uusitupa MI, et al.: Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors. Eur J Nutr 45, 470-477, 2006
27. Goh YK, Jumpsen JA, Ryan EA, and Clandinin MT: Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients. Diabetologia 40, 45-52, 1997. (Pubitemid 27035709)